Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Golpe, O. Castro-Añón, L. A. Pérez de Llano, C. González-Juanatey, M. C. Muñiz-Fernández, A. Testa-Fernández, R. Pérez-Fernández (Lugo, Spain). Prognostic significance of 6-minute walk test in non-group 1 pulmonary hypertension. Eur Respir J 2013; 42: Suppl. 57, 2611

Member's Comments

No comment yet.

Related content which might interest you: Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods Year: 2015 Prognostic impact of oxygen saturation during the 6-minute walk test in pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Comparability of shuttle walk test with 6-minutes walk test in pulmonary diseases with emphasis on pulmonary arterial hypertension Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases Year: 2013 Physiological response to the six-minute walk test in pulmonary arterial hypertension Source: Eur Respir J 2005; 26: 667-672 Year: 2005 Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension Source: Eur Respir J 2012; 40: 1410-1419 Year: 2012 Exercise capacity in chronic obstructive pulmonary disease: Cardiopulmonary exercise testing versus 6-minute walk test Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Blood pressure variability during the 6-minute walk test in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Clinical predictors of pulmonary hypertension in sarcoidosis Source: Eur Respir J 2008; 32: 296-302 Year: 2008 Safety related to maximal cardiopulmonary exercise testing in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Clinical determinants of six-minute walking test in pulmonary sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010 Stops and its correlation with new measurements during the six-minute walk test in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016 The six-minute walking test accompanied by pulse oximetry and ventilation assessment in patients with pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension Source: Eur Respir J 2006; 27: 114-120 Year: 2006 Six-minute walk test correlates with hemodynamic severity in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004 Exercise testing in pulmonary hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Exercise testing in pulmonary hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Exercise testing in pulmonary hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Exercise testing in pulmonary hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018